Satellite Sessions

June 5 | 12:30-14:00

Novartis Israel | June 5 | 12:30-14:00

Title: Innovation in Cardiology – Breaking the Boundaries of Traditional Cardiology

 

Click here to view agenda.

Novo Nordisk - Obesity | June 5 | 12:30-14:00

Title: GLP-1 RA – New insights in obesity and CVD

 

Click here to view agenda.

Medtronic | June 5 | 12:30-14:00

Title: Innovations in treatment of Arrythmia's- From Cardiology in the community to Electrophysiology

 

Click here to view agenda.

Pharma Clinical | June 5 | 12:30-14:00

Title: New Challenges in Heart Failure Treatment

 

Click here to view agenda.

June 6 | 12:30-14:00

Pfizer Pharmaceuticals Israel | June 6 | 12:30-14:00

Title: Idiopathic heart failure or undiagnosed ATTR-CM? Making an early and accurate diagnosis

 

Click here to view agenda.

Novo Nordisk - Diabetes | June 6 | 12:30-14:00

Title: New frontiers in ASCVD with GLP-1 in T2D patients

 

Click here to view agenda.

AstraZeneca (Israel) | June 6 | 12:30-14:00

Title: A new era for cardiorenal patients – Exploring the role of SGLT2i in clinical practice

 

Click here to view agenda.

Abbott Laboratories | June 6 | 12:30-14:00

Title: From TAVI to Mitral and back – Nurse & Technician satellite at IHS

 

Click here to view agenda.

Supported by a Non-Restricted Grant by Edwards Lifesciences | June 6 | 12:30-14:00

Title: Tricuspid valve disease and transcatheter interventions

 

Click here to view agenda.